Related Experiment Video
Updated: Jun 2, 2026

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic Poly(I:C)
Published on: March 25, 2016
Repeated course antenatal steroids, inflammation gene polymorphisms, and neurodevelopmental outcomes at age 2
Erin A S Clark1, Lisa Mele, Ronald J Wapner
1Departments of Obstetrics and Gynecology at the University of Utah, Salt Lake City, UT 84132, USA. erin.clark@hsc.utah.edu
Insights
Repeated antenatal corticosteroids may mitigate neurodevelopmental delay risks linked to the IL-6 -174 GG genotype. This finding suggests a potential protective effect in infants with this genetic predisposition.
Area of Science:
- Perinatology
- Genetics
- Neurodevelopmental Pediatrics
Background:
- Antenatal corticosteroids are used to mature fetal lungs.
- Repeated courses may increase risks for neurodevelopmental issues.
- Inflammation gene polymorphisms are implicated in neurodevelopmental outcomes.
Purpose of the Study:
- To investigate the interaction between repeated antenatal corticosteroid courses and inflammation gene polymorphisms.
- To assess the impact on neurodevelopmental outcomes at 2 years of age.
Main Methods:
- Nested case-control analysis within a randomized controlled trial.
- Comparison of single vs. repeated antenatal corticosteroid courses.
- Analysis of 4 inflammation gene polymorphisms in cases with neurodevelopmental delay versus controls.
Main Results:
- A significant interaction was found between repeated corticosteroids and the interleukin (IL)-6 -174 genotype (P = .046).
- The IL-6 -174 GG genotype was associated with increased neurodevelopmental delay risk in the single-course group (OR, 6.47).
- Repeated antenatal corticosteroids abrogated this genotype-associated risk (OR, 1.30).
Conclusions:
- Repeated-course antenatal steroids may reduce the risk of neurodevelopmental delay associated with the IL-6 -174 GG genotype.
- This suggests a potential protective role of repeated antenatal corticosteroids in genetically susceptible infants.
Objective:
We sought to evaluate the interaction between repeated-course antenatal corticosteroids and inflammation gene polymorphisms with neurodevelopmental outcomes at age 2 years.
Study Design:
We conducted nested case-control analysis of a randomized controlled trial of single- vs repeated-course antenatal corticosteroids. Cases had mental and/or psychomotor delay at age 2 years. Controls had normal neurodevelopment. Previous analyses of 125 cases and 147 controls identified 4 inflammation gene polymorphisms associated with neurodevelopmental delay at age 2 years.
Results:
The interaction between repeated-course corticosteroids and the interleukin (IL)-6 -174 genotype with neurodevelopmental delay was significant (P = .046). The IL-6 -174 GG genotype was associated with neurodevelopmental delay at age 2 years in the single-course corticosteroid group (odds ratio, 6.47; 95% confidence interval, 1.86-22.50). Exposure to repeated-course antenatal corticosteroids abrogated this genotype effect (odds ratio, 1.30; 95% confidence interval, 0.48-3.54). Results were unchanged after controlling for potential confounders.
Conclusion:
Repeated-course antenatal steroids may reduce the increased risk of neurodevelopmental delay at age 2 years associated with IL-6 -174 GG genotype.
Related Concept Videos
Teratogenicity
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Gene-Environment Interactions
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
